Clinical Trials

Accrual Status
Limit to SWOG Trials

1037 Results

Status Trial Number Title Sort descending Activated Closed Accrual Phase Published
Closed S0333 Phase II Double Induction for Newly Diagnosed Non-L3 ALL 4/15/2005 100%
Closed S1001 Phase II Early Stage DLBCL 7/18/2011 6/1/2016 100%
Closed S0125 Phase II Elderly AML in First Complete Remission 4/1/2003 6/1/2005 10%
Closed SWOG-7916 Phase II Evaluation of Gallium Nitrate in Metastatic Urological Malignancies: Testicular, Bladder, Prostate and Kidney 7/20/1979 1/19/1984 Published
Closed SWOG-8304 Phase II Evaluation of L-Alanosine in Metastatic Carcinoma of the Breast 5/27/1983 5/4/1984 Published
Closed SWOG-7918 Phase II Evaluation of m-AMSA in Lymphoma - Hodgkin's and Non-Hodgkin's 7/12/1979 4/14/1981
Closed SWOG-8519 Phase II Evaluation of Methyl-Glyoxal Bis- Guanylhydrazone (MGBG) in Patients With Advanced Bladder Cancer 1/1/1986 5/15/1989 Published
Closed SWOG-7921 Phase II Evaluation of MGBG in Metastatic Carcinoma of the Breast 7/12/1979 10/22/1980
Closed S0805 Phase II HyperCVAD + Dasatinib with or without Allo SCT for Ph+ ALL 9/1/2009 100% Published
Closed S0919 Phase II Idarubicin/AraC + Pravastatin for Relapsed AML 8/15/2009 9/15/2017 100%
Closed S0115 Phase II Melphalan + Auto PBSC Trans. for High Risk MM / Amyloidosis - BMT Study 1/1/2004 10/15/2010 95% Published
Closed S1108 Phase II MLN8237 in Peripheral T-Cell NHL 10/28/2011 6/6/2013 100% Published
Closed S0117 Phase II Mylotarg™ for Relapsed AML 4/1/2003 10/15/2005 60%
Closed S0703 Phase II Older Previously Untreated Non-M3 AML 12/1/2008 93% Published
Closed S0636 Phase II OSI-774/Bevacizumab in Neversmokers with St. IIIB and IV Primary NSCLC Adenocarcinoma 7/15/2007 9/1/2010 100%
Closed S0635 Phase II OSI-774/Bevacizumab in St. IIIB and IV BAC and AdenoBAC 7/15/2007 8/15/2011 95%
Closed SWOG-8364 Phase II Pilot Study of Immediate Post-Operative Adjuvant Chemotherapy in Patients with Operable Breast Cancer 5/27/1983 9/27/1985
Closed S0432 Phase II Previously Untreated AML in Patients of Age 70 or Older 9/15/2004 2/21/2006 100% Published
Closed S0301 Phase II Previously Untreated Non-M3 AML in Patients of Age 56 or Older 10/1/2003 12/15/2006 100% Published
Closed SWOG-226 Phase II Protocol for Porfiromycin Solid Tumors 7/12/1967 100%
Scroll Table